IMMUNITYBIO, INC.
Ownership & governance
Executives 5Directors 9Avg age 64Avg tenure 7y
RA
Richard Adcock
Chief Executive Officer
Age 57Since 2020-09-30Profile →
+13
Executives5
RA
Richard Adcock→
Chief Executive Officer
Age 57Since 2020-09-30
PS
Patrick Soon-Shiong→
Chief Executive Officer
Age 73Since 2015-02-28
DS
David Sachs→
Director of Finance/CFO
Age 48Since 2021-02-28
BB
Bruce Brown→
Chief Tech/Sci/R&D Officer
—Since 2024-08-31
ED
Enrique Dilone→
Chief Tech/Sci/R&D Officer
Age 59Since 2023-08-13
Board of directors9
WC
Wesley Clark→
Director/Board Member
Age 80Since 2021-01-31
CS
Christobel Selecky→
Director/Board Member
Age 71Since 2021-02-28
PS
Patrick Soon-Shiong→
Chairman
Age 73Since 2014-11-30
RA
Richard Adcock→
Director/Board Member
Age 57Since 2021-03-28
BS
Barry Simon→
Director/Board Member
Age 61Since 2006-12-31
MB
Michael Blaszyk→
Director/Board Member
Age 73Since 2015-06-30
CC
Cheryl Cohen→
Director/Board Member
Age 60Since 2019-05-31
LM
Linda Maxwell→
Director/Board Member
Age 52Since 2021-03-28
Shareholders5
| Name | Stake | Shares |
|---|---|---|
| Patrick Soon-Shiong | 37.51 % | 392,906,522 |
| Cambridge Equities LP | 24.99 % | 261,705,814 |
| BlackRock Advisors LLC | 2.261 % | 23,682,287 |
| STATE STREET CORPORATION | 1.691 % | 17,708,103 |
| Vanguard Portfolio Management LLC | 1.558 % | 16,322,844 |
Catalog · 2026-07-09
Registry officers14
| Name | Role | Since | Shares |
|---|---|---|---|
| Bruce Brown | Chief Tech/Sci/R&D Officer | 2024-08-31 | - |
| David Sachs | Director of Finance/CFO | 2021-02-28 | - |
| Enrique Dilone | Chief Tech/Sci/R&D Officer | 2023-08-13 | - |
| Patrick Soon-Shiong | Chairman | 2014-11-30 | - |
| Patrick Soon-Shiong | Chief Executive Officer | 2015-02-28 | - |
| Richard Adcock | Chief Executive Officer | 2020-09-30 | - |
| Barry Simon | Director/Board Member | 2006-12-31 | - |
| Bruce Wendel | Director/Board Member | 2025-12-11 | - |
Registry · as of 2026-07-09
Institutional (13F)
Loading Form 13F holders…
Fund membership
Loading fund baskets…
Street consensus
Consensus strong buyMean target 13.75Range 12–16Analysts 4
12Mean 13.7516
- Strong buy 1
- Buy 3
Broker actions40 of 71
| Firm | Action | To | Target | Date |
|---|---|---|---|---|
| HC Wainwright & Co. | Reiterated | Buy | 15 | 2026-06-02 |
| BTIG | Reiterated | Buy | 12 | 2026-05-21 |
| HC Wainwright & Co. | Reiterated | Buy | 15 | 2026-05-20 |
| D. Boral Capital | Maintained | Buy | 23 | 2026-05-05 |
| D. Boral Capital | Maintained | Buy | 23 | 2026-04-21 |
| D. Boral Capital | Maintained | Buy | 23 | 2026-04-08 |
| D. Boral Capital | Maintained | Buy | 23 | 2026-03-26 |
| D. Boral Capital | Maintained | Buy | 23 | 2026-03-23 |
| D. Boral Capital | Maintained | Buy | 23 | 2026-03-17 |
| D. Boral Capital | Maintained | Buy | 23 | 2026-03-09 |
| Piper Sandler | Reiterated | Overweight | 12 | 2026-03-04 |
| D. Boral Capital | Maintained | Buy | 23 | 2026-02-23 |
Firm rows and rating mix from Yahoo Finance; mean target is Yahoo’s aggregate until OpenFilings derives consensus from broker rows.